» Articles » PMID: 15713718

Active Ghrelin Levels and Active to Total Ghrelin Ratio in Cancer-induced Cachexia

Overview
Specialty Endocrinology
Date 2005 Feb 17
PMID 15713718
Citations 96
Authors
Affiliations
Soon will be listed here.
Abstract

Anorexia and weight loss are negative prognostic factors in patients with cancer. Although total ghrelin levels are increased in energy-negative states, levels of the biologically active octanoylated ghrelin and the anorexigenic peptide YY (PYY) have not been reported in patients with cancer-induced cachexia. We hypothesized that abnormal ghrelin and/or PYY levels contribute to cancer-induced cachexia. We evaluated 21 patients with cancer-induced cachexia; 24 cancer patients without cachexia; and 23 age-, sex-, race-, and BMI-matched subjects without cancer. Active ghrelin levels and the active to total ghrelin ratio were significantly increased in subjects with cancer-induced cachexia, compared with cancer and noncancer controls. PYY levels were similar among groups. Appetite measured by a visual analog scale was not increased in subjects with cachexia. The increase in active ghrelin levels is likely to be a compensatory response to weight loss. Cachexia may be a state of ghrelin resistance because appetite does not correlate with ghrelin levels. Changes in the active to total ghrelin ratio suggest that a mechanism other than increased secretion must be responsible for the increase in active ghrelin levels. PYY is unlikely to play an important role in cancer-induced cachexia.

Citing Articles

Sarcopenia and cachexia: molecular mechanisms and therapeutic interventions.

Wang T, Zhou D, Hong Z MedComm (2020). 2025; 6(1):e70030.

PMID: 39764565 PMC: 11702502. DOI: 10.1002/mco2.70030.


Prognostic Impact and Prevalence of Cachexia in Patients With Heart Failure: A Systematic Review and Meta-Analysis.

Prokopidis K, Irlik K, Hendel M, Piasnik J, Lip G, Nabrdalik K J Cachexia Sarcopenia Muscle. 2024; 15(6):2536-2543.

PMID: 39478303 PMC: 11634528. DOI: 10.1002/jcsm.13596.


The LEAP2 Response to Cancer-Related Anorexia-Cachexia Syndrome in Male Mice and Patients.

Varshney S, Shankar K, Kerr H, Anderson L, Gupta D, Metzger N Endocrinology. 2024; 165(11).

PMID: 39331742 PMC: 11481018. DOI: 10.1210/endocr/bqae132.


Therapeutic potential of ghrelin/GOAT/GHSR system in gastrointestinal disorders.

Ma Y, Yan Q, Wang P, Guo W, Yu L Front Nutr. 2024; 11:1422431.

PMID: 39246401 PMC: 11380557. DOI: 10.3389/fnut.2024.1422431.


Understanding cachexia and its impact on lung cancer and beyond.

Yue M, Qin Z, Hu L, Ji H Chin Med J Pulm Crit Care Med. 2024; 2(2):95-105.

PMID: 39169934 PMC: 11332896. DOI: 10.1016/j.pccm.2024.02.003.